Related Experiment Videos
Short- and long-term results after multivessel stenting in diabetic patients
Roxana Mehran1, George D Dangas, Yoshio Kobayashi
1Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA.
Insights
Diabetic patients undergoing multivessel stenting had higher rates of in-hospital coronary artery bypass graft surgery (CABG), increased target lesion revascularization, and lower one-year survival compared to non-diabetic patients. Diabetes mellitus is an independent predictor of adverse outcomes post-stenting.
Area of Science:
- Cardiology
- Interventional Cardiology
- Diabetes Mellitus Management
Background:
- Coronary artery bypass graft surgery (CABG) has historically shown decreased survival in diabetic patients compared to conventional angioplasty.
- Multivessel stenting has emerged as an alternative, with studies indicating good procedural success and acceptable outcomes.
Purpose of the Study:
- To evaluate the clinical outcomes of diabetic patients following multivessel stenting.
- To compare outcomes across diabetic patients treated with oral agents versus insulin, and non-diabetic patients.
Main Methods:
- A total of 689 patients with 1,639 native coronary lesions underwent multivessel stenting.
- Patients were stratified into three groups: no diabetes mellitus (DM), DM treated with oral agents, and DM treated with insulin.
Main Results:
- Procedural success was high. In-hospital CABG was significantly higher in insulin-treated diabetics (3.5%) compared to other groups (p=0.02).
- Diabetic patients (oral agents or insulin) exhibited higher one-year target lesion revascularization rates (25-35%) versus non-diabetics (16%) (p<0.001).
- One-year survival was lower in diabetic patients (85-86%) compared to non-diabetics (95%) (p<0.001). DM independently predicted mortality, myocardial infarction, and revascularization.
Conclusions:
- Multivessel stenting demonstrates high technical success but carries increased risks for diabetic patients.
- Diabetic patients, particularly those on insulin, face higher in-hospital CABG rates, more frequent revascularization, and reduced one-year survival.
- Diabetes mellitus is a significant independent predictor of adverse clinical outcomes after multivessel stenting.
Objectives:
The present study evaluated clinical outcomes in diabetic patients after multivessel stenting.
Background:
Multivessel angioplasty studies have reported decreased survival in diabetic patients undergoing conventional balloon angioplasty compared with coronary artery bypass graft surgery (CABG). However, several studies have demonstrated excellent procedural success and acceptable clinical outcomes after multivessel stenting.
Methods:
Multivessel stenting was performed in 689 patients with 1,639 native coronary lesions. Patients were classified into three groups according to diabetes mellitus (DM) status: 1) no DM (501 patients/1,200 lesions); 2) DM treated with oral agents (102 patients/235 lesions); and 3) DM treated with insulin (86 patients/204 lesions).
Results:
Procedural success was high overall. In-hospital CABG was higher in diabetics treated with insulin compared with the other two groups (3.5% vs. 0.4% vs. 1.0%, p = 0.02). There were no significant differences in the incidence of in-hospital cardiac death and myocardial infarction. Diabetic patients treated with oral agents or insulin had higher one-year target lesion revascularization rates than non-diabetic patients (25% vs. 35% vs. 16%, p < 0.001). Lower one-year survival was observed in diabetic patients treated with either oral agents or insulin, compared with non-diabetic patients (85% vs. 86% vs. 95%, p < 0.001). On multivariable analysis, DM was an independent predictor of one-year mortality, myocardial infarction, and target lesion revascularization after multivessel stenting.
Conclusions:
Despite a high technical success rate of multivessel stenting, diabetic patients, especially those treated with insulin, have higher in-hospital CABG, higher subsequent revascularization rates, and lower one-year survival than non-diabetic patients.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease III: Interprofessional Care